Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3 on the study record history.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page history now includes an addition of Revision: v3.4.2 and deletions of a government-funding notice and Revision: v3.4.1, which are UI/versioning updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a site-wide funding and operating status notice and updated the revision to v3.4.1, removing the previous v3.4.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedThe history page adds a glossary toggle and legends for color-coded changes (green for additions, red for deletions) and updates the revision label to v3.4.0.SummaryDifference0.4%

- Check82 days agoChange DetectedThe history page now shows Revision: v3.3.4 in place of Revision: v3.3.3. This is a minor site version update.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.